Clinical Trial Update: Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Rheumatoid Arthritis Refractory to Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating fecal microbiota transplantation for efficacy and safety in rheumatoid arthritis refractory to methotrexate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Rheumatoid Arthritis | Phase 2 | Status: UNKNOWN